AsclepiosS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-02-28
Share capital
9 450 000,00 PLN
Activity description

Asclepios S.A. operates a pharmaceutical wholesaler with warehouse facilities. Its activities include sales and telemarketing, nutrition, contract fulfillment and tenders; its DPD certificate has been confirmed by the GIF.

Registered address
Hubska 44, 50-502 Wrocław, Poland
Website
asclepios.plWebsite active
Email
Email warning
Phone
Electronic delivery address
AE:PL-87959-66556-UDUVA-19

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 291.17mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 8.38mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 274.55mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 87.78mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 1995-08-03. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 22,411

MSiG notices

Publication dateEvent
Dec 7, 2020Commercial Companies Code notice
Nov 20, 2020Commercial Companies Code notice
Nov 5, 2020Commercial Companies Code notice
Oct 21, 2020Commercial Companies Code notice

Public aid

11 public aid cases recorded, with a total value of $1,929,397.

PurposeGross amount
Liquidity support for undertakings affected by the war in Ukraine
$398.7K
Liquidity support for undertakings affected by the war in Ukraine
$144.6K
Liquidity support for undertakings affected by the war in Ukraine
$65,537

Tenders

4845 tenders recorded as contractor: 1099 national ($42,143,021) and 3746 EU ($14,188,022,878).

SubjectAmount
Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach
–
Dostawa produktów leczniczych oraz leków w ramach programów lekowych
–
Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach
–

Public sector contracts

Asclepios is the contractor in 1355 public sector contracts, worth PLN 259.43m in total. They were signed with 208 public buyers. The largest number (5) were signed with Uniwersyteckie Centrum Kliniczne.

Public buyerValue
Zespół Opieki Zdrowotnej w OławiePLN 33,122
Szpital Specjalistyczny Im. Jędrzeja Śniadeckiego w Nowym SączuPLN 132,343
Szpital Wojewódzki Im. Kardynała Stefana Wyszyńskiego w ŁomżyPLN 589.05
Uniwersytecki Szpital Kliniczny w BiałymstokuPLN 10,741
Szpital dla Nerwowo I Psychicznie Chorych Im. St. KryzanaPLN 56.00

Public procurement disputes (KIO)

Asclepios has been a party to 11 cases before the National Appeal Chamber (since 2010). It filed 3 appeals (2 upheld, 1 dismissed). In 8 cases it joined the proceedings as a participant.

DateCase no.RoleOther partyOutcome
Jun 3, 2022KIO 1422/22Participant (on appellant's side)Międzyleski Szpital SpecjalistycznyAuthority accepted the complaints
May 26, 2022KIO 1281/22Participant (on appellant's side)Wojewódzki Szpital SpecjalistycznyAuthority accepted the complaints
May 26, 2022KIO 1279/22Participant (on appellant's side)Wojewódzki Szpital SpecjalistycznyAuthority accepted the complaints
Jun 30, 2020KIO 877/20AppellantZakład Zamówień Publicznych przy Ministrze ZdrowiaAuthority accepted the complaints
Sep 19, 2019KIO 1775/19Participant (on authority's side)Centralny Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i AdministracjiAuthority accepted the complaints

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Tomasz Arkadiusz Jóźwik – President of the Management Board
Artur Rzegocki – Vice President of the Management Board
Bartłomiej Jan Sawicki – Attorney-in-fact (sole)

Manner of representation

The following are authorized to represent the company and act on its behalf: 1. the President of the Management Board independently; 2. two members of the management board or one member of the management board jointly with a commercial proxy; 3. an independent commercial proxy independently.

Supervisory board

Paweł Andrzej Szewczyk – Supervisory Board Member
Krzysztof Bernard Wojtas – Supervisory Board Member
Wiesław Bociek – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
15%

Competitors

Name
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.
Salus Internationalsp. z o.o.
HurtapS.A.
Sanofisp. z o.o.
USP Zdrowiesp. z o.o.
MSD Polska Dystrybucjasp. z o.o.
Medi&Moresp. z o.o.
Bialmedsp. z o.o.
Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A.
Phoenix Pharma Polskasp. z o.o.

Change history

DateEvent
2021-06-18Share capital change
2018-03-28Share capital change
2016-03-31Share capital change
2012-06-28Share capital change
2011-08-16Share capital change

FAQ

Last updated: 2026-06-22